Translocation of a gut pathobiont drives autoimmunity in mice and humans.
Silvio M VieiraMichael HiltenspergerV KumarDaniel Zegarra RuizCarina A DehnerN KhanF R C CostaEleni TiniakouTeri M GreilingWilliam E RuffA BarbieriC KriegelSameet MehtaJames R KnightDhanpat JainAndrew L GoodmanMartin A KriegelPublished in: Science (New York, N.Y.) (2018)
Despite multiple associations between the microbiota and immune diseases, their role in autoimmunity is poorly understood. We found that translocation of a gut pathobiont, Enterococcus gallinarum, to the liver and other systemic tissues triggers autoimmune responses in a genetic background predisposing to autoimmunity. Antibiotic treatment prevented mortality in this model, suppressed growth of E. gallinarum in tissues, and eliminated pathogenic autoantibodies and T cells. Hepatocyte-E. gallinarum cocultures induced autoimmune-promoting factors. Pathobiont translocation in monocolonized and autoimmune-prone mice induced autoantibodies and caused mortality, which could be prevented by an intramuscular vaccine targeting the pathobiont. E. gallinarum-specific DNA was recovered from liver biopsies of autoimmune patients, and cocultures with human hepatocytes replicated the murine findings; hence, similar processes apparently occur in susceptible humans. These discoveries show that a gut pathobiont can translocate and promote autoimmunity in genetically predisposed hosts.
Keyphrases
- drug induced
- liver injury
- multiple sclerosis
- high glucose
- endothelial cells
- celiac disease
- gene expression
- diabetic rats
- systemic lupus erythematosus
- cardiovascular events
- ejection fraction
- end stage renal disease
- newly diagnosed
- high fat diet induced
- risk factors
- dna methylation
- genome wide
- cardiovascular disease
- type diabetes
- oxidative stress
- circulating tumor
- single molecule
- insulin resistance
- coronary artery disease
- cell free
- replacement therapy